Skip to main content

Advertisement

Log in

The clinical role of stress myocardial perfusion imaging in women with suspected coronary artery disease

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Cardiovascular disease remains the number one cause of mortality for women in the United States, with coronary artery disease (CAD) accounting for 54% of all cardiovascular deaths. CAD claims the lives of more than 250,000 women each year and is therefore the single largest killer of American women. For several decades, the underrepresentation of women in clinical trials led to both a lack of available sex-specific evidence and a generalized misconception that CAD was a “man's disease.” In actuality, not only are women vulnerable to CAD, they typically develop it 10 to 15 years later than men. Furthermore, sex differences exist in the mortality rates of women and men with CAD, such that once CAD is present in women, they have worse outcomes than their male counterparts. Consequently, early and accurate diagnosis of CAD is crucial for reducing mortality rates in women. Stress myocardial perfusion imaging (MPI) using contemporary techniques has been shown to have significant value in the diagnosis and prognosis of CAD in women. In the risk assessment of women with an intermediate clinical pretest likelihood of CAD, using MPI with exercise or pharmacologic stress has been shown to add incremental value to clinical variables or exercise electrocardiogram stress testing alone. This review discusses the clinical role of stress MPI in the management of women with suspected CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. American Heart Association: 2003 Heart and Stroke Statistical Update. Dallas: American Heart Association; 2003.

    Google Scholar 

  2. Shaw LJ, Miller DD, Romeis JC, et al.: Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994, 120:559–556.

    PubMed  CAS  Google Scholar 

  3. Tobin JN, Wassertheil-Smoller S, Wexler JP, et al.: Sex bias in considering coronary bypass surgery. Ann Intern Med 1987, 107:19–25.

    PubMed  CAS  Google Scholar 

  4. Douglas PS, Ginsburg GS: The evaluation of chest pain in women. N Engl J Med 1996, 334:1311–1315.

    Article  PubMed  CAS  Google Scholar 

  5. Steingart RM, Packer M, Hamm P, et al.: Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med 1991, 325:226–230.

    Article  PubMed  CAS  Google Scholar 

  6. Kilaru PK, Kelly RF, Calvin JE, Parillo JE: Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart association guidelines. J Am Coll Cardiol 2000, 35:974–979.

    Article  PubMed  CAS  Google Scholar 

  7. Mark DB, Shaw LK, Delong ER, et al.: Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med 1994, 330:1101–1106.

    Article  PubMed  CAS  Google Scholar 

  8. Hochleitner M: Coronary heart disease: sexual bias in referral for coronary angiogram. How does it work in a state-run health system? J Wom Health Gen Based Med 2000, 9:29–34.

    Article  CAS  Google Scholar 

  9. Wong CC, Froelicher ES, Bacchetti P, et al.: Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiography. Circulation 1997, 96:II–51-II–57.

    PubMed  CAS  Google Scholar 

  10. Mosca L, Grundy SM, Judelson D, et al.: AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. J Am Coll Cardiol 1999, 33:1751–1755.

    Article  PubMed  CAS  Google Scholar 

  11. Mieres JH, Shaw LJ, Hendel RC, et al.: Consensus statement from the American Society of Nuclear Cardiology Task Force on Women and Heart Disease. The role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women. J Nucl Cardiol 2003, 10:95–101. A comprehensive review of the available evidence on stress MPI in the diagnosis and prognosis of women with suspected CAD.

    Article  PubMed  Google Scholar 

  12. Cacciabaudo JM, Hachamovitch R: Stress myocardial perfusion SPECT in women: is it the cornerstone of the noninvasive evaluation? J Nucl Med 1998, 39:756–758.

    PubMed  CAS  Google Scholar 

  13. Goodgold HM, Rehder JG, Samuels LD, Chaitman BR: Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women: characterization of breast attenuation artifacts. Radiology 1987, 165:361–366.

    PubMed  CAS  Google Scholar 

  14. Hansen CL, Crabbe D, Rubin S: Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber. J Am Coll Cardiol 1996, 67:69–77.

    Google Scholar 

  15. Kwok Y, Kim C, Grady D, et al.: Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999, 83:660–666.

    Article  PubMed  CAS  Google Scholar 

  16. Santana-Boado C, Candell-Riera J, Castell-Conesa, et al.: Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998, 39:751–755.

    PubMed  CAS  Google Scholar 

  17. Taillefer R, DePuey EG, Udelson JE, et al.: Diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997, 29:69–77.

    Article  PubMed  CAS  Google Scholar 

  18. Heller GV, Fossati AT: Detection of coronary artery disease in women. In Nuclear Cardiology: State of the Art and Future Directions, edn 2. Edited by Zaret B, Beller G. Philadelphia: Mosby; 1999.

    Google Scholar 

  19. Friedman TD, Greene AC, Iskandrain AS, et al.: Exercise thallium-201 myocardial perfusion scintigraphy in women: correlation with coronary arteriography. Am J Cardiol 1982, 49:1632–1637.

    Article  PubMed  CAS  Google Scholar 

  20. Amanullah AM, Berman DS, Hachamovitch R, et al.: Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT. Am J Cardiol 1997, 80:132–137.

    Article  PubMed  CAS  Google Scholar 

  21. Kong BA, Shaw L, Miller DD, Chaitman BR: Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Am J Cardiol 1992, 70:168–173.

    Article  PubMed  CAS  Google Scholar 

  22. Amanullah AM, Berman DS, Erol J, et al.: Incremental prognostic value of adenosine myocardial perfusion singlephoton emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998, 82:725–730.

    Article  PubMed  CAS  Google Scholar 

  23. Hachamovitch R, Berman DS, Kiat H, et al.: Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996, 28:34–44.

    Article  PubMed  CAS  Google Scholar 

  24. Travin MI, Duca MD, Kline GM, et al.: Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997, 134:73–82.

    Article  PubMed  CAS  Google Scholar 

  25. Ficaro EP, Shreve PD, Kirtzman JN, et al.: Evaluation of attenuation corrected cardiac SPECT perfusion imaging in women. Circulation 1996 94(Suppl 8):I-13.

    Google Scholar 

  26. Berman DS, Kang X, Hayes SW, et al.: Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003, 41:1125–1133.

    Article  PubMed  Google Scholar 

  27. Giri S, Shaw LJ, Murthy DR, Travin MI, et al.: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002, 105:32–40. A multicenter trial demonstrating the prognostic role of MPI in a large cohort of women and men with diabetes mellitus.

    Article  PubMed  Google Scholar 

  28. Amanullah AM, Kiat H, Hachamovitch R, et al.: Impact of myocardial perfusion single-photon emission computed tomography on referral to catheterization of the very elderly. Is there evidence of gender-related referral bias? J Am Coll Cardiol 1996, 28:680–686.

    PubMed  CAS  Google Scholar 

  29. Gibbons RJ, Hodge DO, Berman DS, et al.: Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999, 100:2140–2145.

    PubMed  CAS  Google Scholar 

  30. Gibbons RJ, Chatterjee K, Daley J, et al.: ACC/ AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 1999, 3:2092–2197.

    Article  Google Scholar 

  31. Galassi AR, Azzarelli S, Tomaselli A, et al.: Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected of known coronary artery disease. Am J Cardiol 2001, 88:101–106.

    Article  PubMed  CAS  Google Scholar 

  32. Vanzetto G, Ormezzano O, Farget D, et al.: Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6 year follow-up. Circulation 1999, 100:1521–1527.

    PubMed  CAS  Google Scholar 

  33. Olmos LI, Dakik H, Gordon R, et al.: Long-term prognostic value of exercise echocardiography compared with exercise 201 Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998, 98:2679–2686.

    PubMed  CAS  Google Scholar 

  34. Alkeylani A, Miller DD, Shaw LJ, et al.: Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris. Am J Cardiol 1998, 81:293–297.

    Article  PubMed  CAS  Google Scholar 

  35. Snader CE, Marwick TH, Pashkow FJ, et al.: Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 1997, 30:641–648.

    Article  PubMed  CAS  Google Scholar 

  36. Boyne TS, Koplan BA, Parsons WJ, et al.: Predicting adverse outcome with exercise SPECT technetium-99m-sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol 1997, 79:270–274.

    Article  PubMed  CAS  Google Scholar 

  37. Geleijnse ML, Elhendy A, van Domburg RT, et al.: Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997, 96:137–147.

    PubMed  CAS  Google Scholar 

  38. Heller GV, Herman SD, Travin MI, et al.: Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995, 26:1202–1208.

    Article  PubMed  CAS  Google Scholar 

  39. Machecourt J, Longere P, Pagret D, et al.: Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 1994, 23:1096–1106.

    Article  PubMed  CAS  Google Scholar 

  40. Kamal AM, Fattah AA, Pancholy S, et al.: Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1994, 1:254–261.

    Article  PubMed  CAS  Google Scholar 

  41. Stratman HG, Tamesis BR, Younis LT, et al.: Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994, 73:647–652.

    Article  Google Scholar 

  42. Stratman HG, Williams GA, Wittry MD, et al.: Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994, 89:615–622.

    Google Scholar 

  43. Groutars RG, Verzijbergen JF, Muller AJ, et al.: Prognostic value and quality of life in patients with normal rest thallium-201/ stress technetium 99m-tetreosofmin dual isotope myocardial SPECT. J Nucl Cardiol 2000, 7:333–341.

    Article  PubMed  CAS  Google Scholar 

  44. Soman P, Parsons A, Lahiri N, Lahiri A: The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999, 6:252–256.

    Article  PubMed  CAS  Google Scholar 

  45. Yao SS, Rozanski A: Principal uses of myocardial perfusion scintigraphy in the management of patients with known or suspected coronary artery disease. Prog Cardiovasc Dis 2001, 43:281–302.

    Article  PubMed  CAS  Google Scholar 

  46. Hendel R, Chen M, L' Italien G, et al.: Sex differences in perioperative and long term cardiac event-free survival in vascular surgery patients. Circulation 1995, 91:1044–1051.

    PubMed  CAS  Google Scholar 

  47. Marwick T, Shaw L, Lauer M, et al.: The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease: Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999, 106:172–178. A large observational, prognostic, multicenter series of women and men who had noninvasive testing with stress MPI.

    Article  PubMed  CAS  Google Scholar 

  48. Pancholy S, Fattah A, Kamal A, et al.: Independent and incremental prognostic value of exercise thallium single-photon emission tomographic imaging in women. J Nucl Cardiol 1995, 2:110–116.

    PubMed  CAS  Google Scholar 

  49. Sharir T, Germano G, Kavanagh PB, et al.: Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999, 100:1035–1042.

    PubMed  CAS  Google Scholar 

  50. Barret-Connor EL, Cohen BA, Wingard DL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than men? The Rancho Bernardo study. JAMA 1991, 265:627–631.

    Article  Google Scholar 

  51. Kang X, Berman DS, Lewin HC, et al.: Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999, 138:1025–1032.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mieres, J.H., Rosman, D.R. & Shaw, L.J. The clinical role of stress myocardial perfusion imaging in women with suspected coronary artery disease. Curr Cardiol Rep 6, 27–31 (2004). https://doi.org/10.1007/s11886-004-0062-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-004-0062-3

Keywords

Navigation